Results 21 to 30 of about 18,462 (237)

Antipsychotic Drug-Like Effects of the Selective M4 Muscarinic Acetylcholine Receptor Positive Allosteric Modulator VU0152100 [PDF]

open access: bronzeNeuropsychopharmacology, 2014
Nellie Byun   +20 more
openalex   +2 more sources

Clozapine is responsible for the in vivo imaging and pharmacological effects of clozapine-N-oxide in murine DREADD models [PDF]

open access: yesFrontiers in Pharmacology
Although clozapine-N-oxide (CNO), a major metabolite of clozapine (CLZ), is a widely used agonist of designer receptors exclusively activated by designer drugs (DREADDs), the compound responsible for visualizing or activating DREADDs in nuclear medicine ...
Jian Wang   +14 more
doaj   +2 more sources

Structural and Dynamic Mechanisms of Allostery at the M4 Muscarinic Acetylcholine Receptor

open access: greenSocial Science Research Network, 2022
Ziva Vuckovic   +23 more
openalex   +2 more sources

Downstream Signaling of Muscarinic M<sub>4</sub> Receptors Is Regulated by Receptor Density and Cellular Environment. [PDF]

open access: yesPharmacol Res Perspect
ABSTRACT Multiple muscarinic M4 receptor modulators are currently advancing in clinical development for the treatment of positive symptoms in schizophrenia, including agonists and positive allosteric modulators. Considering the importance of comprehending M4 receptor pharmacology for these therapeutic applications, this study investigates M4 receptor ...
Merz M   +5 more
europepmc   +2 more sources

Mechanisms of Pilocarpine-Induced Nitric Oxide and Prostaglandin Production in Porcine Ciliary Muscle. [PDF]

open access: yesFASEB Bioadv
Pilocarpine activates M1 and M3 muscarinic receptors in porcine ciliary muscle, engaging calcium‐dependent phospholipase C (PLC), nitric oxide synthase (NOS), and cyclooxygenase (COX) pathways that increase prostaglandin E2 (PGE2) synthesis. Beyond nitric oxide (NO) modulation, PGE2 emerges as a key mediator linking muscarinic signaling to ciliary ...
Benozzi G   +3 more
europepmc   +2 more sources

The M4 muscarinic acetylcholine receptor positive allosteric modulator VU0467154 normalizes non‐rapid eye movement sleep deficits in non‐pathologically aged mice.

open access: yesAlzheimer's & Dementia, 2023
The central cholinergic system plays an important role in normal arousal and sleep/wake architecture, and is known to decline in non‐pathological aging and Alzheimer’s disease (AD).
Jason K. Russell   +5 more
semanticscholar   +1 more source

Anti-inflammation of spirocyclopiperazinium salt compound LXM-10 targeting α7 nAChR and M4 mAChR and inhibiting JAK2/STAT3 pathway in rats. [PDF]

open access: yesPLoS ONE, 2013
The present study aims to investigate the therapeutic effects of LXM-10 by intragastric administration in both acute and chronic inflammatory models, and to explore the underlying molecular mechanisms.
Weiwei Zhang   +5 more
doaj   +1 more source

The Neuropathology of Alcohol Use Disorder: Cellular Insights From Human Post-Mortem Studies. [PDF]

open access: yesJ Neurochem
Major cellular changes in alcohol use disorder human post‐mortem brain. Alcohol use disorder (AUD) is a complex neurological disorder that undergoes neural changes, mainly degeneration and or cellular alterations impacting addiction behaviours. Key brain regions implicated in AUD are the cortex, striatum, corpus callosum, hippocampus, hypothalamus ...
Rasool AE, Cornish JL, Prasad AA.
europepmc   +2 more sources

Xanomeline displays concomitant orthosteric and allosteric binding modes at the M4 mAChR

open access: yesNature Communications, 2023
The M4 muscarinic acetylcholine receptor (M4 mAChR) has emerged as a drug target of high therapeutic interest due to its expression in regions of the brain involved in the regulation of psychosis, cognition, and addiction.
Wessel A. C. Burger   +16 more
doaj   +1 more source

Home - About - Disclaimer - Privacy